Microbio Co

Microbio Co EBITDA per Share

The EBITDA per Share of Microbio Co (4128.TWO) as of Oct 16, 2026 is -0.69 TWD. In the previous year, EBITDA per Share was -0.77 TWD — a change of -9.87% (higher).

EBITDA per Share

-0.69TWD

YoY

-9.87%

Last updated:

EBITDA per Share of Microbio Co is 2025 -0.69 TWD. EBITDA per Share of Microbio Co was 2024 -0.77 TWD. It decreases by -9.87% higher compared to the previous year.

The Microbio Co EBITDA per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA per Share
Date
EBITDA per Share
Jan 1, 2018
-1.42 TWD
Jan 1, 2019
-0.51 TWD
Jan 1, 2020
1.11 TWD
Jan 1, 2021
-0.43 TWD
Jan 1, 2022
0.28 TWD
Jan 1, 2023
-0.90 TWD
Jan 1, 2024
-0.77 TWD
Jan 1, 2025
-0.69 TWD
The Microbio Co EBITDA per Share history
YEAREBITDA per ShareYoY
-0.69TWD-9.87%
-0.77TWD-15.17%
-0.90TWD-420.71%
0.28TWD-165.74%
-0.43TWD-138.51%
1.11TWD-320.32%
-0.51TWD-64.28%
-1.42TWD-245.38%
0.97TWD-250.12%
-0.65TWD-3.76%
-0.67TWD-3.36%
-0.70TWD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Microbio Co Stock analysis

What does Microbio Co do? Microbio Co Ltd is a company based in Taipei City, Taiwan, operating within the Consumer Staples sector and the Consumer products industry. The company went public on February 10, 2003, with its stock ticker listed as 4128.TWO and ISIN code TW0004128004. Its primary operations include the research, development, manufacture, and sale of healthcare and consumer products. Microbio Co Ltd offers a range of fermentation-based products, such as Tien Chun Bao (TCB) oral solutions, as well as herbal products under the LeeHerb series. The company also provides organic foods, including vegetables, fruits, nuts, pastries, seasonings, and organic meals. While the company develops and sells new medicines, including treatments for cancer, hepatitis, allergies, and rheumatoid arthritis, it primarily focuses on the domestic market for distribution. Microbio Co Ltd's website is https://www.microbio.com.tw/. The company's activities are centered on product innovation and meeting consumer needs within Taiwan's domestic market, with no indication of international expansion or significant acquisitions mentioned in the provided information. The company's business model emphasizes the production and distribution of health-oriented consumer goods, leveraging its research and development capabilities to create a diverse portfolio of products. Microbio Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Microbio Co stock

EBITDA per Share of Microbio Co is -0.69 TWD in 2025.

EBITDA per Share of Microbio Co changed from -0.77 TWD to -0.69 TWD, representing a -9.87% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBITDA per Share Microbio Co since 2006 – with annual values, charts, and detailed analysis.

EBITDA per share divides EBITDA by shares outstanding, showing the operating cash earnings allocated to each share before depreciation and financing effects.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Microbio Co

All Key Metrics — Microbio Co